Subscribe now

For our monthly insights digest


Click here for the Privacy Statement.

Invalid Captcha
Thank you for subscribing to DKSH insights. You will receive an email confirming your subscription shortly.

Analgesic Medicine Achieves Sales Growth Despite Pandemic Challenges Listen with ReadSpeaker

Despite the challenges of COVID-19, DKSH has pivoted to help an analgesic medicine to secure continued growth and position itself as an appropriate first line analgesic medicine to relieve acute and chronic pain for postoperative pain management.

Business Units


Business Lines




The client’s objective was to develop and supply physicians and healthcare providers products that enhance health and quality of life. Its initial focus was gastroenterology featuring a unique probiotic that has a positive effect on the gut’s microflora.

It has since expanded into other therapeutic areas like pain management, neurology, otolaryngology, and rheumatology. Its portfolio of products is found in five continents via a network of wholly-owned subsidiaries, licensees, distributors, and licensed retailers.

Analgesic Medicine Achieves Sales Growth Despite Pandemic Challenges

DKSH helped us instill confidence among doctors and healthcare professionals in Thailand for our product. More importantly, it managed to deliver the message to healthcare practitioners and patients even during the COVID-19 pandemic.

Client’s company representative